Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.
about
Pharmacokinetic drug interactions in liver disease: An updateLidocaine metabolismLiver enzyme induction and inhibition: implications for anaesthesia.Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms.Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores.The role of hepatic cytochrome P-450 in sepsis.CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug InterventionThe effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.Effect of erythromycin and rifampicin on monoethylglycinexylidide test.Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function.Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro.Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.Lidocaine metabolism in isolated perfused liver from streptozotocin-induced diabetic rats.
P2860
Q26774479-30C3B6DC-25CA-46DE-8923-A795CB5AF862Q30230806-D17FD267-5700-4811-B41F-F66178E7DDB7Q34487131-C05AD84B-DB23-491A-B397-8E79EDF5AC77Q34692592-A136B259-262E-448A-A0FC-DE3DFE9FE33EQ35015993-398A32CE-7E30-44CC-AFFF-B78D2BFBC493Q35959053-854E5D98-8D0E-48A6-BF82-F425B190F897Q36186137-5FA3F886-DBEC-4E1E-AA6E-2E6F47091A96Q37157901-A877C083-50C4-418F-812A-3753236D8FAAQ37492051-AD336AD6-ED20-4AE5-B2E4-B0C1BEC80E53Q37633942-65AEB0D9-2B27-4FDC-98BC-6A623C8F747CQ37717030-B93DF594-D406-4DD9-9106-01703DFA9F89Q37770251-41F463B1-AF25-4DE7-A03F-9E123AF2CC50Q42142006-89E8DDE2-4808-4F01-9C3E-8E3FAC3DA508Q46237124-E3ABC8AD-65EC-4EDB-B6F1-F76921C985D9Q47099468-91EC179E-9DFE-4642-9E22-F8C8FF657FECQ48669897-18FDEB73-5C97-4C77-813A-AE2973B63024Q48677642-0B9D25D1-0FB7-4763-8B29-D347F7F96DE9
P2860
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Cytochrome P450 1A2 is a major ...... vo: effects of liver function.
@en
Cytochrome P450 1A2 is a major ...... vo: effects of liver function.
@nl
type
label
Cytochrome P450 1A2 is a major ...... vo: effects of liver function.
@en
Cytochrome P450 1A2 is a major ...... vo: effects of liver function.
@nl
prefLabel
Cytochrome P450 1A2 is a major ...... vo: effects of liver function.
@en
Cytochrome P450 1A2 is a major ...... vo: effects of liver function.
@nl
P2093
P1476
Cytochrome P450 1A2 is a major ...... vo: effects of liver function.
@en
P2093
Maura Floreani
Pierpaolo Piccoli
Pietro Palatini
Roberto Padrini
Rocco Orlando
P356
10.1016/J.CLPT.2003.09.007
P407
P577
2004-01-01T00:00:00Z